{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:47:21Z","timestamp":1792784841533,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"42","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573858"],"award-info":[{"award-number":["82573858"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81902603"],"award-info":[{"award-number":["81902603"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research Fund of Zhongnan Hospital of Wuhan University","id":[{"id":"https:\/\/ror.org\/01v5mqw79","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of Hubei Province"},{"name":"Natural Science Foundation of Hubei Province"},{"name":"Natural Science Foundation of Hubei Province"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,11,4]]},"DOI":"10.1038\/s41388-026-03973-9","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T18:00:26Z","timestamp":1788199226000},"page":"4498-4511","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["POC1A promotes the proliferation, metastasis and stemness of bladder cancer by stabilizing BMI1 via USP7"],"prefix":"10.1038","volume":"45","author":[{"given":"Houyi","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renran","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7009-3116","authenticated-orcid":false,"given":"Jianmin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingdong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4153-1265","authenticated-orcid":false,"given":"Kaiyu","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangjin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0813-3628","authenticated-orcid":false,"given":"Lingao","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5388-1276","authenticated-orcid":false,"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1377-9685","authenticated-orcid":false,"given":"Yu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4690-9020","authenticated-orcid":false,"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"3973_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"3973_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12:31\u201346.","journal-title":"Cancer Discov"},{"key":"3973_CR3","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.stem.2024.04.004","volume":"31","author":"JJ Loh","year":"2024","unstructured":"Loh JJ, Ma S. Hallmarks of cancer stemness. Cell Stem Cell. 2024;31:617\u201339.","journal-title":"Cell Stem Cell"},{"key":"3973_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202308438","volume":"11","author":"Y Xiao","year":"2024","unstructured":"Xiao Y, Jin W, Qian K, Ju L, Wang G, Wu K, et al. Integrative single cell atlas revealed intratumoral heterogeneity generation from an adaptive epigenetic cell state in human bladder urothelial carcinoma. Adv Sci (Weinh). 2024;11:e2308438.","journal-title":"Adv Sci (Weinh)"},{"key":"3973_CR5","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41568-020-00313-1","volume":"21","author":"L Tran","year":"2021","unstructured":"Tran L, Xiao JF, Agarwal N, Duex JE, Theodorescu D. Advances in bladder cancer biology and therapy. Nat Rev Cancer. 2021;21:104\u201321.","journal-title":"Nat Rev Cancer"},{"key":"3973_CR6","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41388-023-02932-y","volume":"43","author":"F Zhou","year":"2024","unstructured":"Zhou F, Deng Z, Shen D, Lu M, Li M, Yu J, et al. DLGAP5 triggers proliferation and metastasis of bladder cancer by stabilizing E2F1 via USP11. Oncogene. 2024;43:594\u2013607.","journal-title":"Oncogene"},{"key":"3973_CR7","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.7150\/thno.102730","volume":"15","author":"Z Deng","year":"2025","unstructured":"Deng Z, Zhou F, Li M, Jin W, Yu J, Wang G, et al. DLGAP5 enhances bladder cancer chemoresistance by regulating glycolysis through MYC stabilization. Theranostics. 2025;15:2375\u201392.","journal-title":"Theranostics"},{"key":"3973_CR8","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.7150\/jca.19967","volume":"8","author":"R Cao","year":"2017","unstructured":"Cao R, Wang G, Qian K, Chen L, Qian G, Xie C, et al. Silencing of HJURP induces dysregulation of cell cycle and ROS metabolism in bladder cancer cells via PPARgamma-SIRT1 feedback loop. J Cancer. 2017;8:2282\u201395.","journal-title":"J Cancer"},{"key":"3973_CR9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1242\/jcs.111203","volume":"126","author":"M Venoux","year":"2013","unstructured":"Venoux M, Tait X, Hames RS, Straatman KR, Woodland HR, Fry AM. Poc1A and Poc1B act together in human cells to ensure centriole integrity. J Cell Sci. 2013;126:163\u201375.","journal-title":"J Cell Sci"},{"key":"3973_CR10","doi-asserted-by":"publisher","first-page":"5378","DOI":"10.1093\/hmg\/ddv261","volume":"24","author":"A Koparir","year":"2015","unstructured":"Koparir A, Karatas OF, Yuceturk B, Yuksel B, Bayrak AO, Gerdan OF, et al. Novel POC1A mutation in primordial dwarfism reveals new insights for centriole biogenesis. Hum Mol Genet. 2015;24:5378\u201387.","journal-title":"Hum Mol Genet"},{"key":"3973_CR11","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/cge.14672","volume":"107","author":"U Altunoglu","year":"2025","unstructured":"Altunoglu U, Turgut GT, Ozturan EK, Kalayci T, Kaya M, Toksoy G, et al. Expanding the clinical and mutational spectrum of biallelic POC1A variants: characterization of four patients and a comprehensive review of POC1A-related phenotypes. Clin Genet. 2025;107:390\u2013401.","journal-title":"Clin Genet"},{"key":"3973_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18135","volume":"28","author":"ZH Li","year":"2024","unstructured":"Li ZH, Li JY, Wu ZT, Zhu YJ, Zhuo T, Nong JS, et al. Upregulation of POC1A in lung adenocarcinoma promotes tumour progression and predicts poor prognosis. J Cell Mol Med. 2024;28:e18135.","journal-title":"J Cell Mol Med"},{"key":"3973_CR13","doi-asserted-by":"publisher","first-page":"5003","DOI":"10.21037\/tcr-23-2398","volume":"13","author":"H Zhou","year":"2024","unstructured":"Zhou H, Zhang M, Zhang X, Du X, Cao H, Bi X. Analysis of the role of POC1A in the development and progression of hepatocellular carcinoma. Transl Cancer Res. 2024;13:5003\u201320.","journal-title":"Transl Cancer Res"},{"key":"3973_CR14","first-page":"173","volume":"6","author":"S Zucoloto","year":"1985","unstructured":"Zucoloto S, Rossi MA, Wright NA, Allison M, Muccillo G. Rupture of the control mechanism of the crypt and villus of the small intestine in experimental chronic alcoholism. Acta Med Port. 1985;6:173\u20139.","journal-title":"Acta Med Port"},{"key":"3973_CR15","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s10020-025-01315-1","volume":"31","author":"Y Qian","year":"2025","unstructured":"Qian Y, Che Y, Li S, Zhang X, Li Q, Zhu Y, et al. POC1A induces epithelial-mesenchymal transition to promote growth and metastasis through the STAT3 signaling pathway in triple-negative breast cancer. Mol Med. 2025;31:280.","journal-title":"Mol Med"},{"key":"3973_CR16","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41580-021-00341-1","volume":"22","author":"A Piunti","year":"2021","unstructured":"Piunti A, Shilatifard A. The roles of Polycomb repressive complexes in mammalian development and cancer. Nat Rev Mol Cell Biol. 2021;22:326\u201345.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3973_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2022.147129","volume":"856","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Yang W, Zheng K, Chen J, Jin X. The role of BMI1 in endometrial cancer and other cancers. Gene. 2023;856:147129.","journal-title":"Gene"},{"key":"3973_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119270","volume":"273","author":"A Sarkar","year":"2021","unstructured":"Sarkar A, Saha S, Paul A, Maji A, Roy P, Maity TK. Understanding stem cells and its pivotal role in regenerative medicine. Life Sci. 2021;273:119270.","journal-title":"Life Sci"},{"key":"3973_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41416-025-03234-8","volume":"134","author":"J Guo","year":"2026","unstructured":"Guo J, Shi X, Sun Y, Long R, Wu H, Ye F, et al. Bmi1 represses HLF to drive the formation and development of intrahepatic cholangiocarcinoma. Br J Cancer. 2026;134:33\u201344.","journal-title":"Br J Cancer"},{"key":"3973_CR20","doi-asserted-by":"publisher","first-page":"8231","DOI":"10.3390\/ijms23158231","volume":"23","author":"J Xu","year":"2022","unstructured":"Xu J, Li L, Shi P, Cui H, Yang L. The crucial roles of Bmi-1 in cancer: implications in pathogenesis, metastasis, drug resistance, and targeted therapies. Int J Mol Sci. 2022;23:8231.","journal-title":"Int J Mol Sci"},{"key":"3973_CR21","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s11010-013-1745-0","volume":"382","author":"W Liang","year":"2013","unstructured":"Liang W, Zhu D, Cui X, Su J, Liu H, Han J, et al. Knockdown BMI1 expression inhibits proliferation and invasion in human bladder cancer T24 cells. Mol Cell Biochem. 2013;382:283\u201391.","journal-title":"Mol Cell Biochem"},{"key":"3973_CR22","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3892\/or.2013.2919","volume":"31","author":"D Zhu","year":"2014","unstructured":"Zhu D, Wan X, Huang H, Chen X, Liang W, Zhao F, et al. Knockdown of Bmi1 inhibits the stemness properties and tumorigenicity of human bladder cancer stem cell-like side population cells. Oncol Rep. 2014;31:727\u201336.","journal-title":"Oncol Rep"},{"key":"3973_CR23","doi-asserted-by":"publisher","first-page":"18310","DOI":"10.18632\/aging.203277","volume":"13","author":"MK Chen","year":"2021","unstructured":"Chen MK, Zhou JH, Wang P, Ye YL, Liu Y, Zhou JW, et al. BMI1 activates P-glycoprotein via transcription repression of miR-3682-3p and enhances chemoresistance of bladder cancer cell. Aging. 2021;13:18310\u201330.","journal-title":"Aging"},{"key":"3973_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-020-00775-3","volume":"21","author":"D Chen","year":"2021","unstructured":"Chen D, Cheng L, Cao H, Liu W. Role of microRNA-381 in bladder cancer growth and metastasis with the involvement of BMI1 and the Rho\/ROCK axis. BMC Urol. 2021;21:5.","journal-title":"BMC Urol"},{"key":"3973_CR25","first-page":"8813","volume":"23","author":"L Zhang","year":"2019","unstructured":"Zhang L, Wang CZ, Ma M, Shao GF. MiR-15 suppressed the progression of bladder cancer by targeting BMI1 oncogene via PI3K\/AKT signaling pathway. Eur Rev Med Pharm Sci. 2019;23:8813\u201322.","journal-title":"Eur Rev Med Pharm Sci"},{"key":"3973_CR26","doi-asserted-by":"publisher","first-page":"5718","DOI":"10.1002\/cam4.5316","volume":"12","author":"J Xie","year":"2023","unstructured":"Xie J, Ni J, Shi H, Wang K, Ma X, Li W, et al. LncRNA SNHG3 enhances BMI1 mRNA stability by binding and regulating c-MYC: Implications for the carcinogenic role of SNHG3 in bladder cancer. Cancer Med. 2023;12:5718\u201335.","journal-title":"Cancer Med"},{"key":"3973_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/gpbjnl\/qzaf072","volume":"23","author":"S Zhang","year":"2025","unstructured":"Zhang S, Chen X, Jin E, Wang A, Chen T, Zhang X, et al. The GSA family in 2025: a broadened sharing platform for multi-omics and multimodal data. Genom Proteom Bioinforma. 2025;23:qzaf072.","journal-title":"Genom Proteom Bioinforma"},{"key":"3973_CR28","doi-asserted-by":"publisher","first-page":"D30","DOI":"10.1093\/nar\/gkae978","volume":"53","author":"Members","year":"2025","unstructured":"Members, Partners C-N. Database resources of the National Genomics Data Center, China National Center for Bioinformation in 2025. Nucleic Acids Res. 2025;53:D30\u2013D44.","journal-title":"Nucleic Acids Res"},{"key":"3973_CR29","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/nprot.2016.174","volume":"12","author":"X Liu","year":"2017","unstructured":"Liu X, Krawczyk E, Suprynowicz FA, Palechor-Ceron N, Yuan H, Dakic A, et al. Conditional reprogramming and long-term expansion of normal and tumor cells from human biospecimens. Nat Protoc. 2017;12:439\u201351.","journal-title":"Nat Protoc"},{"key":"3973_CR30","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/ctm2.36","volume":"10","author":"Y Luo","year":"2020","unstructured":"Luo Y, Ju L, Wang G, Chen C, Wang Y, Chen L, et al. Comprehensive genomic profiling of urothelial carcinoma cell lines reveals hidden research bias and caveats. Clin Transl Med. 2020;10:294\u20136.","journal-title":"Clin Transl Med"},{"key":"3973_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.95","volume":"10","author":"W Liu","year":"2020","unstructured":"Liu W, Ju L, Cheng S, Wang G, Qian K, Liu X, et al. Conditional reprogramming: modeling urological cancer and translation to clinics. Clin Transl Med. 2020;10:e95.","journal-title":"Clin Transl Med"},{"key":"3973_CR32","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1042\/CS20190587","volume":"133","author":"S Cheng","year":"2019","unstructured":"Cheng S, Wang G, Wang Y, Cai L, Qian K, Ju L, et al. Fatty acid oxidation inhibitor etomoxir suppresses tumor progression and induces cell cycle arrest via PPARgamma-mediated pathway in bladder cancer. Clin Sci (Lond). 2019;133:1745\u201358.","journal-title":"Clin Sci (Lond)"},{"key":"3973_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/srep35783","volume":"6","author":"G Wang","year":"2016","unstructured":"Wang G, Cao R, Wang Y, Qian G, Dan HC, Jiang W, et al. Simvastatin induces cell cycle arrest and inhibits proliferation of bladder cancer cells via PPARgamma signalling pathway. Sci Rep. 2016;6:35783.","journal-title":"Sci Rep"},{"key":"3973_CR34","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nature01587","volume":"423","author":"IK Park","year":"2003","unstructured":"Park IK, Qian D, Kiel M, Becker MW, Pihalja M, Weissman IL, et al. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature. 2003;423:302\u20135.","journal-title":"Nature"},{"key":"3973_CR35","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.7150\/ijbs.70441","volume":"18","author":"J Yu","year":"2022","unstructured":"Yu J, Shen C, Lin M, Chen X, Dai X, Li Z, et al. BMI1 promotes spermatogonial stem cell maintenance by epigenetically repressing Wnt10b\/beta-catenin signaling. Int J Biol Sci. 2022;18:2807\u201320.","journal-title":"Int J Biol Sci"},{"key":"3973_CR36","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1158\/1535-7163.MCT-20-0774","volume":"20","author":"F Jernigan","year":"2021","unstructured":"Jernigan F, Branstrom A, Baird JD, Cao L, Dali M, Furia B, et al. Preclinical and early clinical development of ptc596, a novel small-molecule tubulin-binding agent. Mol Cancer Ther. 2021;20:1846\u201357.","journal-title":"Mol Cancer Ther"},{"key":"3973_CR37","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1093\/labmed\/lmac083","volume":"54","author":"X Li","year":"2023","unstructured":"Li X, Liu J, Li A, Liu X, Miao Y, Wang Z. Analysis of the relationship between bladder cancer gene mutation and clinical prognosis by high-throughput sequencing. Lab Med. 2023;54:142\u201352.","journal-title":"Lab Med"},{"key":"3973_CR38","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1172\/JCI200420800","volume":"113","author":"IK Park","year":"2004","unstructured":"Park IK, Morrison SJ, Clarke MF. Bmi1, stem cells, and senescence regulation. J Clin Invest. 2004;113:175\u20139.","journal-title":"J Clin Invest"},{"key":"3973_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70566","volume":"14","author":"F Shaalan","year":"2025","unstructured":"Shaalan F, Ballout N, Chamoun WT. Insights into the role of bmi-1 deregulation in promoting stemness and therapy resistance in glioblastoma: a narrative review. Cancer Med. 2025;14:e70566.","journal-title":"Cancer Med"},{"key":"3973_CR40","doi-asserted-by":"publisher","first-page":"301","DOI":"10.32604\/or.2024.053764","volume":"33","author":"J Reyes-Carmona","year":"2025","unstructured":"Reyes-Carmona J. Insights on Bmi-1 therapeutic targeting in head and neck cancers. Oncol Res. 2025;33:301\u20137.","journal-title":"Oncol Res"},{"key":"3973_CR41","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.stem.2020.06.022","volume":"27","author":"L Jia","year":"2020","unstructured":"Jia L, Zhang W, Wang CY. BMI1 inhibition eliminates residual cancer stem cells after PD1 blockade and activates antitumor immunity to prevent metastasis and relapse. Cell Stem Cell. 2020;27:238\u2013253 e236.","journal-title":"Cell Stem Cell"},{"key":"3973_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04268-5","volume":"12","author":"AE Herzog","year":"2021","unstructured":"Herzog AE, Warner KA, Zhang Z, Bellile E, Bhagat MA, Castilho RM, et al. The IL-6R and Bmi-1 axis controls self-renewal and chemoresistance of head and neck cancer stem cells. Cell Death Dis. 2021;12:988.","journal-title":"Cell Death Dis"},{"key":"3973_CR43","doi-asserted-by":"publisher","first-page":"23405","DOI":"10.1021\/acsnano.3c04636","volume":"17","author":"M Zhu","year":"2023","unstructured":"Zhu M, Fan H, Deng J, Jiang K, Liao J, Zhang X, et al. BMI1 silencing liposomes suppress postradiotherapy cancer stemness against radioresistant hepatocellular carcinoma. ACS Nano. 2023;17:23405\u201321.","journal-title":"ACS Nano"},{"key":"3973_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.130309","volume":"263","author":"NJ Guo","year":"2024","unstructured":"Guo NJ, Wang B, Zhang Y, Kang HQ, Nie HQ, Feng MK, et al. USP7 as an emerging therapeutic target: a key regulator of protein homeostasis. Int J Biol Macromol. 2024;263:130309.","journal-title":"Int J Biol Macromol"},{"key":"3973_CR45","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.gendis.2020.10.004","volume":"9","author":"A Al-Eidan","year":"2022","unstructured":"Al-Eidan A, Wang Y, Skipp P, Ewing RM. The USP7 protein interaction network and its roles in tumorigenesis. Genes Dis. 2022;9:41\u201350.","journal-title":"Genes Dis"},{"key":"3973_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1509","volume":"13","author":"Y He","year":"2023","unstructured":"He Y, Jiang S, Zhong Y, Wang X, Cui Y, Liang J, et al. USP7 promotes non-small-cell lung cancer cell glycolysis and survival by stabilizing and activating c-Abl. Clin Transl Med. 2023;13:e1509.","journal-title":"Clin Transl Med"},{"key":"3973_CR47","first-page":"299","volume":"10","author":"N Zheng","year":"2020","unstructured":"Zheng N, Chu M, Lin M, He Y, Wang Z. USP7 stabilizes EZH2 and enhances cancer malignant progression. Am J Cancer Res. 2020;10:299\u2013313.","journal-title":"Am J Cancer Res"},{"key":"3973_CR48","doi-asserted-by":"publisher","first-page":"9332","DOI":"10.7150\/thno.47137","volume":"10","author":"X Dai","year":"2020","unstructured":"Dai X, Lu L, Deng S, Meng J, Wan C, Huang J, et al. USP7 targeting modulates anti-tumor immune response by reprogramming tumor-associated macrophages in lung cancer. Theranostics. 2020;10:9332\u201347.","journal-title":"Theranostics"},{"key":"3973_CR49","doi-asserted-by":"publisher","first-page":"133","DOI":"10.21873\/anticanres.13934","volume":"40","author":"J Li","year":"2020","unstructured":"Li J, Vangundy Z, Poi M. PTC209, a specific inhibitor of BMI1, promotes cell cycle arrest and apoptosis in cervical cancer cell lines. Anticancer Res. 2020;40:133\u201341.","journal-title":"Anticancer Res"},{"key":"3973_CR50","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1080\/15384101.2018.1469872","volume":"17","author":"Y Kong","year":"2018","unstructured":"Kong Y, Ai C, Dong F, Xia X, Zhao X, Yang C, et al. Targeting of BMI-1 with PTC-209 inhibits glioblastoma development. Cell Cycle. 2018;17:1199\u2013211.","journal-title":"Cell Cycle"},{"key":"3973_CR51","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13045-016-0247-4","volume":"9","author":"A Bolomsky","year":"2016","unstructured":"Bolomsky A, Schlangen K, Schreiner W, Zojer N, Ludwig H. Targeting of BMI-1 with PTC-209 shows potent anti-myeloma activity and impairs the tumour microenvironment. J Hematol Oncol. 2016;9:17.","journal-title":"J Hematol Oncol"},{"key":"3973_CR52","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1200\/JCO.23.01684","volume":"42","author":"BA Van Tine","year":"2024","unstructured":"Van Tine BA, Ingham MA, Attia S, Meyer CF, Baird JD, Brooks-Asplund E, et al. Phase Ib study of unesbulin (PTC596) plus dacarbazine for the treatment of locally recurrent, unresectable or metastatic, relapsed or refractory leiomyosarcoma. J Clin Oncol. 2024;42:2404\u201314.","journal-title":"J Clin Oncol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03973-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03973-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03973-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:37:58Z","timestamp":1791959878000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03973-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":52,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2026,11,4]]}},"alternative-id":["3973"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03973-9","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"assertion":[{"value":"17 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"For human samples: this study was approved by the Medical Ethics Committee of Zhongnan Hospital of Wuhan University (approval number: 2024061\u2009K). All methods were performed in accordance with the relevant guidelines and regulations. For animal study: the study was approved by the Experimental Animal Welfare Ethics Committee at Zhongnan Hospital of Wuhan University (approval number: ZN2023152). All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","label":"Ethical statement","group":{"name":"EthicsHeading","label":"Ethics"}}]}}